Interaction Details


Details of experiments between Q92796 and Q9NS75
Note that the results of all experiments are listed, regardless of the modification states of the fragments.


Experiment series 1

Protein A

Protein: DLG3
Fragment: 381-476
Site: PDZ_3
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: Biotin-ado-ado-SVWLRKETRV
Average holdup BI: 0.78
Normalized holdup BI: 0.92
Immobilized partner concentration (10-6M): 18
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 1
Measured pKd: 5.92
PUBMED ID: 36115835
Experimental Details

Crude peptide synthesis product. The peptide concentration in the affinity conversion step may differ from reality. Not reported internal standards of holdup layout #6

Experiment series 2

Protein A

Protein: DLG3
Fragment: 381-476
Site: PDZ_3
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.66
Holdup BI standard deviation: 0.11
Normalized holdup BI: 0.84
Normalized holdup BI standard deviation: 0.14
Immobilized partner concentration (10-6M): 27
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 2
Measured pKd: 5.34
PUBMED ID: 36115835

Experiment series 3

Protein A

Protein: DLG3
Fragment: 221-314
Site: PDZ_2
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.67
Holdup BI standard deviation: 0
Normalized holdup BI: 0.83
Normalized holdup BI standard deviation: 0
Immobilized partner concentration (10-6M): 27
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 2
Measured pKd: 5.32
PUBMED ID: 36115835

Experiment series 4

Protein A

Protein: DLG3
Fragment: 221-314
Site: PDZ_2
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: Biotin-ado-ado-SVWLRKETRV
Average holdup BI: 0.72
Normalized holdup BI: 0.76
Immobilized partner concentration (10-6M): 18
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 1
Measured pKd: 5.32
PUBMED ID: 36115835
Experimental Details

Crude peptide synthesis product. The peptide concentration in the affinity conversion step may differ from reality. Not reported internal standards of holdup layout #6

Experiment series 5

Protein A

Protein: DLG3
Fragment: 221-314
Site: PDZ_2
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.49
Immobilized partner concentration (10-6M): 6.7
Experiment method: SAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normal layout
Number of measurements: 1
Measured pKd: 5.31
PUBMED ID: 36115835

Experiment series 6

Protein A

Protein: DLG3
Fragment: 381-476
Site: PDZ_3
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.3
Immobilized partner concentration (10-6M): 6.7
Experiment method: SAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normal layout
Number of measurements: 1
Measured pKd: 4.89
PUBMED ID: 36115835

Experiment series 7

Protein A

Protein: DLG3
Fragment: 124-219
Site: PDZ_1
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.23
Immobilized partner concentration (10-6M): 6.7
Experiment method: SAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normal layout
Number of measurements: 1
Measured pKd: 4.71
PUBMED ID: 36115835

Experiment series 8

Protein A

Protein: DLG3
Fragment: 124-219
Site: PDZ_1
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: Biotin-ado-ado-SVWLRKETRV
Average holdup BI: 0.43
Normalized holdup BI: 0.45
Immobilized partner concentration (10-6M): 18
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 1
Measured pKd: 4.71
PUBMED ID: 36115835
Experimental Details

Crude peptide synthesis product. The peptide concentration in the affinity conversion step may differ from reality. Not reported internal standards of holdup layout #6

Experiment series 9

Protein A

Protein: DLG3
Fragment: 124-219
Site: PDZ_1
Construct: his6-MBP-TEVsite-PDZ

Protein B

Protein: CYSLTR2
Fragment: 337-346
Site: PBM
Sequence: SVWLRKETRV
Construct: biotin-ttds-SVWLRKETRV
Average holdup BI: 0.39
Holdup BI standard deviation: 0.01
Normalized holdup BI: 0.39
Normalized holdup BI standard deviation: 0.01
Immobilized partner concentration (10-6M): 27
Experiment method: DAPF_holdup
Details of affinity fitting: fluorescein + mCherry internal standards + normalization based on CALIP_holdup data + reverse layout
Number of measurements: 2
Measured pKd: 4.41
PUBMED ID: 36115835